Prescient to announce Phase 1b cancer trial results at world’s largest haematology conference
Prescient Therapeutics (ASX:PTX) has announced that its abstract for the results of a Phase 1b...
Prescient Therapeutics (ASX:PTX) has announced that its abstract for the results of a Phase 1b...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.